dc.contributor.author | Carmona-Fonseca, Jaime | spa |
dc.contributor.author | Arango Flórez, Eliana María | spa |
dc.date.accessioned | 2020-10-27T14:20:22Z | |
dc.date.available | 2020-10-27T14:20:22Z | |
dc.date.issued | 2012-08-10 | |
dc.identifier.issn | 2382-4603 | |
dc.identifier.issn | 0123-7047 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12749/10196 | |
dc.description.abstract | Antecedentes: Los esquizonticidas anti-Plasmodium schizontocides falciparum reducen la gametocitemia, sin erradicarla; por ello, se adiciona primaquina (PQ). Esta se administra al terminar el esquizonticida: día 4; 0,75 mg/kg; dosis única (régimen estándar). Las artemisininas actúan sobre gametocitos inmaduros I-IV de P. falciparum; la PQ actúa sobre gametocitos maduros (estadio V). ¿Cuál es la eficacia antigametocitos de la combinación esquizonticida-PQ? Objetivo: Analizar la eficacia de PQ-régimen estándar , asociada al regimen esquizonticida. Metodología: Revisión sistemática de los artículos hallados en Pubmed y Lilacs. Resultados y conclusiones: Ningún esquizonticida elimina totalmente los gametocitos en 6-7 días iniciales de tratamiento. | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | spa | spa |
dc.publisher | Universidad Autónoma de Bucaramanga UNAB | |
dc.relation | https://revistas.unab.edu.co/index.php/medunab/article/view/1641/1521 | |
dc.relation.uri | https://revistas.unab.edu.co/index.php/medunab/article/view/1641 | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | |
dc.source | MedUNAB; Vol. 15 Núm. 1 (2012): Aneurisma Cerebral, Imágenes Diagnósticas, Accidentes Biológicos; 14-21 | |
dc.subject | Malaria | |
dc.subject | Plasmodium falciparum | |
dc.subject | Primaquine | |
dc.subject | Gametocytes | |
dc.subject | Transmission blocking | |
dc.subject | Colombia | |
dc.subject | Primaquina | |
dc.subject | Gametocitos | |
dc.subject | Bloqueo de transmisión | |
dc.title | Primaquina, gametocitemia de Plasmodium falciparum y bloqueo de transmisión: ineficacia del actual régimen de dosificación | |
dc.type.driver | info:eu-repo/semantics/article | |
dc.type.local | Artículo | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | |
dc.identifier.instname | instname:Universidad Autónoma de Bucaramanga UNAB | spa |
dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.relation.references | Alano P. Plasmodium falciparumgametocytes: still many
secrets of a hidden life. Mol Microbiol 2007; 66: 291-302 | |
dc.relation.references | Carter R, Graves P Gametocytes. In: Wernsdorfer W,
McGregor S (ed). Malaria. Principles and practice of
malariology. Edinburgh, London, Melbourne and New
York: Churchill Livingstone,1988. Vol 1:253-99. | |
dc.relation.references | Fujioka H, Aikawa M. The malaria parasite and its lifecycle. In: Wahlgren M, Perlmann P (ed). Malaria
molecular and clinical aspects. Amsterdam: Editorial
Harwood Academic Publishers, 1999:21-36 | |
dc.relation.references | Talman A, Dormarle O, McKenzie F, Ariey F, Robert V.
Gametocytogenesis: the puberty of Plasmodium
falciparum. Malar J 2004; 14(3):24 | |
dc.relation.references | Bousema T, Roeffen W, Meijerink H, Mwerinde H, Mwakalinga S, van Gemert G, et al. The dynamics of
naturally acquired immune responses to Plasmodium
falciparum sexual stage antigens Pfs230 & Pfs48/45 in a
low endemic area in Tanzania. PLoS One 2010-a; 5(11):
e14114. | |
dc.relation.references | Contreras-Ochoa C, Ramsey J. Gametocitos de
Plasmodium vivax y Plasmodium falciparum: etapas
relegadas en el desarrollo de vacunas. Salud Publ
México 2004; 46: 64-70. | |
dc.relation.references | Baker D. Malaria gametocytogenesis. Mol Biochem Parasitol 2010; 172: 57-85 | |
dc.contributor.cvlac | Arango Flórez, Eliana María [Eliana-Arango-Florez] | |
dc.identifier.repourl | repourl:https://repository.unab.edu.co | |
dc.description.abstractenglish | Background: Anti-Plasmodium schizontocides falciparum schizonticides reduce gametocythemia, without eradicating it; therefore, primaquine (PQ) is added. This is administered at the end of the schizontocide: day 4; 0.75mg/kg; single dose (standard regimen). Artemisinins act on immature gametocytes I-IV of P. falciparum; PQ acts on mature gametocytes (stage V). What is the antigametocyte efficacy of the schizontocide-PQ combination? Objective: To analyze the efficacy of PQ-standard regimen, associated with the schizontocidal regimen. Methodology: Systematic review of the articles found in Pubmed and Lilacs. Results and conclusions: No schizontocide completely eliminates gametocytes in the initial 6-7 days of treatment. | eng |
dc.type.redcol | http://purl.org/redcol/resource_type/ART | |